The lights on Griffith's bridge across the Smith Street Motorway have turned a lovely shade of pink in support of the fight against breast cancer.
Patients with drug resistant forms of breast cancer and some forms of pancreatic cancer may have new hope, thanks to a new drug first developed at Griffith and now being trialled in the Czech Republic.
There is new hope in the fight against resistant forms of breast cancer as Griffith Health Institute (GHI) research aims to target the disease with novel anti-cancer agents. Breast cancer occurs when abnormal cells in the breast grow in an uncontrolled way. In 2009, breast cancer was the most common cancer in Australian women (excluding nonmelanoma skin cancer), […]
Studying the genetic variations that predispose individuals to breast cancer has been the fuel for study for Honours student Julian Fang from Arundel.
New hope is on its way for the fight against breast cancer as Griffith Health Institute (GHI) research aims to target the disease with immune-based therapies.